𝔖 Bobbio Scriptorium
✦   LIBER   ✦

O9. Inhibition of osteoclastic resorption in vivo during the reversal phase of the bone remodelling cycle

✍ Scribed by Skerry, TM; Hillam, R.A.


Book ID
122808816
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
155 KB
Volume
15
Category
Article
ISSN
8756-3282

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The tyrosine kinase inhibitor dasatinib
✍ Kate Vandyke; Andrea L Dewar; Peter Diamond; Stephen Fitter; Christopher G Schul πŸ“‚ Article πŸ“… 2010 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 423 KB

## Abstract Dasatinib is a potent tyrosine kinase inhibitor that is used to treat chronic myeloid leukemia in patients resistant or intolerant to imatinib mesylate. While designed to inhibit Abl and Src kinases, dasatinib shows multitarget effects, including inhibition of the macrophage colony‐stim